News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
MT Newswires40d agoneutral
Summit Secures $2 Billion AstraZeneca Investment, Cancer Drug Trial CollaborationSimply Wall St.40d agoneutral
Bristol Myers Squibb (BMY) Stock Trades Below Fair Value As Caution LingersInsider Monkey41d agoneutral
Could Bristol-Myers Squibb (BMY)’s New Myeloma Data Reshape its Growth Outlook?Insider Monkey41d agoneutral
Bristol-Myers Squibb (BMY) is Building its Next Growth Engine. Can It Replace Lost Revenue?Motley Fool42d agobullish
Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?MarketBeat42d agoneutral
Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability ReviewInsider Monkey44d agoneutral
Novartis (NVS) and Bristol Myers (BMY) Pause Autoimmune CAR-T Studies. Can Their Programs Recover?Simply Wall St.45d agoneutral
Bristol Myers Squibb (BMY) Adds Restricted Pharmacy Path For New Myeloma DrugMotley Fool45d agobullish
Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?24/7 Wall St.46d agoneutral
4 Elite Dividend Stocks Yielding Up to 6.14% With Diversified Pipelines That Protect Your Payout